Previous Close | 2.6000 |
Open | 2.0500 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 43.00 |
Expire Date | 2024-06-21 |
Day's Range | 1.8800 - 2.7100 |
Contract Range | N/A |
Volume | |
Open Interest | 2.63k |
PRINCETON, N.J., May 29, 2024--Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line...
NORTHAMPTON, MA / ACCESSWIRE / May 28, 2024 /Originally published on Bristol Myers Squibb News & Perspectives Globally, communities are struggling to support growing healthcare needs. This is especially true in regions with limited financial resources, ...
PRINCETON, N.J., May 23, 2024--Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications....